$122.69
0.85%
Nasdaq, Jan 02, 10:00 pm CET
ISIN
US89377M1099
Symbol
TMDX

TransMedics Group, Inc. Stock price

$122.69
-19.08 13.46% 1M
-5.00 3.92% 6M
+1.04 0.85% YTD
+56.19 84.50% 1Y
+60.97 98.78% 3Y
+103.69 545.74% 5Y
+106.69 666.81% 10Y
+106.69 666.81% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+1.04 0.85%

New AI Insights on TransMedics Group, Inc. Insights AI Insights on TransMedics Group, Inc.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$4.2b
Enterprise Value
$4.2b
Net debt
$45.5m
Cash
$466.2m
Shares outstanding
34.2m
Valuation (TTM | estimate)
P/E
54.5 | 46.1
P/S
7.4 | 6.8
EV/Sales
7.5 | 6.9
EV/FCF
35.1
P/B
11.8
Financial Health
Equity Ratio
28.4%
Return on Equity
15.5%
ROCE
11.1%
ROIC
20.1%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$566.4m | $612.9m
EBITDA
$96.3m | $148.2m
EBIT
$96.0m | $104.8m
Net Income
$91.8m | $90.9m
Free Cash Flow
$120.6m
Growth (TTM | estimate)
Revenue
41.2% | 38.8%
EBITDA
203.1% | 293.0%
EBIT
205.1% | 179.6%
Net Income
181.2% | 156.5%
Free Cash Flow
200.1%
Margin (TTM | estimate)
Gross
60.3%
EBITDA
17.0% | 24.2%
EBIT
16.9%
Net
16.2% | 14.8%
Free Cash Flow
21.3%
More
EPS
$2.3
FCF per Share
$3.5
Short interest
35.1%
Employees
728
Rev per Employee
$610.0k
Show more

Is TransMedics Group, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

TransMedics Group, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a TransMedics Group, Inc. forecast:

16x Buy
80%
4x Hold
20%

Analyst Opinions

20 Analysts have issued a TransMedics Group, Inc. forecast:

Buy
80%
Hold
20%

Financial data from TransMedics Group, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
566 566
41% 41%
100%
- Direct Costs 225 225
38% 38%
40%
341 341
43% 43%
60%
- Selling and Administrative Expenses 180 180
15% 15%
32%
- Research and Development Expense 65 65
29% 29%
11%
96 96
203% 203%
17%
- Depreciation and Amortization 0.30 0.30
0% 0%
0%
EBIT (Operating Income) EBIT 96 96
205% 205%
17%
Net Profit 92 92
181% 181%
16%

In millions USD.

Don't miss a Thing! We will send you all news about TransMedics Group, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

TransMedics Group, Inc. Stock News

Neutral
PRNewsWire
4 days ago
ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44th Annual J.P.
Positive
The Motley Fool
7 days ago
These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery.
Neutral
PRNewsWire
10 days ago
ANDOVER, Mass. , Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 22, 2025, TransMedics granted non-qualified stock options to purchase an aggregate of 6,333 shares of its common stock and an ...
More TransMedics Group, Inc. News

Company Profile

TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.

Head office United States
CEO Waleed Hassanein
Employees 728
Founded 1998
Website www.transmedics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today